Diasome Pharmaceuticals, Inc.

New Filing
CIK: 0001411617·Other Health Care·DELAWARE·Filed: Aug 15, 2024
Total Offering

$15,555,620

Amount Sold

$3,090,740

Investors

4

First Sale

Jul 31, 2024

Offering Details

Type
Equity, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Robert Geho
Related Person
W. Blair Geho
Related Person
THOMAS MCDONALD
Related Person
Frank McCaney
Related Person
Cosme Ordonez
Related Person
Peter Tollman
Related Person

Company

Diasome Pharmaceuticals, Inc.

10000 CEDAR AVENUE

CLEVELAND, OH, 44106

216-444-7110

SEC Filing

0001411617-24-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Diasome Pharmaceuticals, Inc. Form D Filing — $15,555,620 | FilingFlow